7.06
-0.42 (-5.61%)
Penutupan Terdahulu | 7.48 |
Buka | 7.12 |
Jumlah Dagangan | 12,421 |
Purata Dagangan (3B) | 75,949 |
Modal Pasaran | 13,282,956 |
Harga / Jualan (P/S) | 4.06 |
Harga / Buku (P/B) | 0.900 |
Julat 52 Minggu | |
Tarikh Pendapatan | 9 Aug 2024 |
Hasil Dividen (DY TTM) | 21.25% |
Margin Keuntungan | 52.46% |
Margin Operasi (TTM) | -153.67% |
EPS Cair (TTM) | -24.38 |
Jumlah Hutang/Ekuiti (D/E MRQ) | 1.48% |
Nisbah Semasa (MRQ) | 4.75 |
Pulangan Atas Aset (ROA TTM) | -71.92% |
Pulangan Atas Ekuiti (ROE TTM) | -269.31% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Pharmaceutical Retailers (US) | Bercampur | Bercampur |
Pharmaceutical Retailers (Global) | Bercampur | Menurun | |
Stok | TRxADE HEALTH, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
Konsensus Penganalisis | NA |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | -2.0 |
Purata Bergerak Teknikal | -2.5 |
Osilator Teknikal | 0.0 |
Purata | -1.50 |
Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its products and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Superlatus, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc. |
|
Sektor | Healthcare |
Industri | Pharmaceutical Retailers |
Gaya Pelaburan | Small Value |
% Dimiliki oleh Orang Dalam | 63.99% |
% Dimiliki oleh Institusi | 10.25% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Hasil Dividen (DY TTM) | 21.25% |
Purata Hasil Dividen 1T | 0.00% |
Jangkaan Pembayaran Dividen Seterusnya | Jul 2025 |
Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
---|---|---|---|
19 Jul 2024 | 08 Jul 2024 | 24 Jul 2024 | 1.5 Tunai |
25 Mar 2024 | 28 Feb 2024 | 22 Mar 2024 | 8 Tunai |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |